Biogen Pharmachem Stock: price and insider trades · India
Biogen Pharmachem: what insiders have been doing
Biogen Pharmachem is a listed company. Filings by its managers are published through SEBI (PIT + SAST). Between 10 November 2025 and 10 November 2026, 3 insiders published 3 filings.
Only sales appear on the open market, 3 sales in all, filed by 3 insiders. No amount is published for 3 filings, which the totals therefore leave out.
Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
With 3 filings in twelve months, the company is quieter than the median of 4 filings across the 1,986 companies we follow on the same exchange. Over the whole record (from 2026), the tally stands at no purchases and 3 sales.
This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 40,303,000 shares-MarketSEBI:4781856b1807af326cf57752754426fa8e5937b0
- 39,932,000 shares-MarketSEBI:3b2cb6fee28c9c43d3691084ea8fac7d46ac16a8
- 47,500,000 shares-MarketSEBI:d1ad9914e380e678d616e8a794f1f076bc074d7e
3 of 3 declarations
About Biogen Pharmachem
Biogen Pharmachem is a company specializing in the manufacturing of pharmaceutical and chemical products. It operates in the XBOM market.